جست‌وجوی استاد و پژوهشگر

Henrique Miguel Martiniano Vazão de Almeidaمشاهده پروفایل

پژوهشگر

• Biomaterials
• Tissue Engineering
• Regenerative Medicine
• +۳ مورد دیگر

Henrique Miguel Martiniano Vazão de Almeida is a Bioengineer and Materials Engineer affiliated with CENIMAT|i3N at NOVA University Lisbon (Faculty of Science and Technology, Department of Materials Engineering). He completed his bachelor's and master's degrees in Materials Engineering at NOVA University Lisbon (2007) and earned his PhD in Bioengineering from Trinity College Dublin (supervised by Daniel J. Kelly and Fergal O'Brien). His career includes industry experience in biomaterials, postdoctoral work at the University of Coimbra's biomaterials lab (2016-2018), and current research at CENIMAT|i3N (since 2022) supported by FCT CEEC funding (2021). Education: BSc/MSc in Materials Engineering (NOVA University Lisbon, 2007), PhD in Bioengineering (Trinity College Dublin) Henrique specializes in naturally occurring biomaterials for tissue engineering and regenerative medicine. His work focuses on leveraging biomaterials' topography, conductivity, and mechanical properties to regenerate cardiac tissue and develop in vitro models. Recent projects include conductive biomaterials for cardiac tissue engineering and point-of-care devices for disease management. His 15 most recent publications (2016-2021) emphasize 3D printing, extracellular matrix functionalization, and injectable hydrogels for cartilage and cardiac tissue regeneration, spanning interdisciplinary fields like Bioengineering, Materials Science, and Biotechnology. Scientific Awards iBETXplore junior principal investigator funding (2019) FCT CEEC funding for scientific employment (2021) Henrique leads research projects in cardiac tissue engineering at ITQB/iBET (2018-2021) and CENIMAT|i3N (since 2022). His collaborations include work with Prof. Lino Ferreira (University of Coimbra) and institutions like Trinity College Dublin.

Miriam Breunigمشاهده پروفایل

دانشیار

• Pharmaceutical Technology
• Nanomedicine
• Drug Delivery Systems
• +۷ مورد دیگر

apl. Prof. Dr. Miriam Breunig is Associate Professor (apl. Prof.) of Pharmaceutical Technology at the University of Regensburg, Germany, and heads a research group developing nanoparticle-based drug- and vaccine-delivery systems. Since 2023 she serves as Co-Editor-in-Chief of the European Journal of Pharmaceutics and Biopharmaceutics and in 2024 was appointed Galenus Foundation Guest Professor at MIT. Education & Career: 1996-2001: Undergraduate pharmacy studies, Ruprecht-Karls-University Heidelberg 2002-2005: Graduate researcher, Univ. Regensburg (Prof. Göpferich) 2008 & 2009: Post-doctoral fellow, MIT (Prof. Robert Langer) 2013: Habilitation in Pharmaceutical Technology, Univ. Regensburg since 2012: Akademische Rätin (Associate Professor), Dept. Pharmaceutical Technology, Univ. Regensburg Research Focus: The Breunig group engineers innovative delivery platforms for small molecules, proteins and nucleic acids. Core projects include silica- and mesoporous-silica nanoparticle vaccines against HIV-1 and SARS-CoV-2 , injectable hydrogels that provide sustained nanoparticulate antigen release for single-dose immunisation, and nanoparticle-based glaucoma therapy targeting the trabecular meshwork/Schlemm's canal with siRNA or ROCK inhibitors. Publication Trends: Recent articles (2020-2024) concentrate on multivalent antigen display on silica nanoparticles to enhance B-cell activation and durable antibody responses, long-acting hydrogel depots for HIV vaccines, ocular nanoparticle targeting for glaucoma, and mechanistic studies on nanoparticle functionalisation, ECM penetration and controlled release. Editorial & Honours: Co-Editor-in-Chief, Eur J Pharm Biopharm (since 2023) Co-Editor, same journal (2013-2023) Galenus Foundation Guest Professor, MIT (2024) Collaborations & Funding: She coordinates projects within the HIVacToGC consortium, collaborates with Prof. Mika Lindén (mesoporous silica), Prof. Rudolf Fuchshofer (ocular pharmacology) and partners at MIT, and has secured funding for vaccine and glaucoma nanomedicine initiatives.

Peter Campochiaroمشاهده پروفایل

استاد

• Ophthalmology
• Retinal Diseases
• Oxidative Stress
• +۷ مورد دیگر

Peter Campochiaro is a Professor of Ophthalmology at the Johns Hopkins School of Medicine, Department of Ophthalmology, where he conducts cutting-edge research on retinal diseases. He is affiliated with the Neuroscience Training Program and the Visual Neuroscience Training Program, reflecting his interdisciplinary approach. His research focuses on the neurobiology of retinal degeneration, particularly retinitis pigmentosa (RP) and age-related macular degeneration (AMD). He investigates the role of oxidative stress in secondary cone death in RP and the transition to neovascular AMD, exploring therapeutic strategies such as antioxidant supplementation and gene therapy to enhance endogenous defense systems. His recent publications demonstrate a strong trend in developing sustained delivery systems for anti-VEGF agents, gene therapy vectors (AAV), and nonviral nanoparticles for suprachoroidal delivery. His work spans basic science, translational models, and clinical trials, especially in diabetic macular edema and neovascular AMD. Professor of Ophthalmology, Johns Hopkins University Research focus: Oxidative stress, retinal degeneration, gene therapy Active in clinical trials for sustained ocular drug delivery Scientific Awards: No awards explicitly mentioned in the provided text. Advising and Grants: Dr. Campochiaro mentors numerous graduate students and postdoctoral researchers, many of whom appear as co-authors on his publications. His research is supported by extensive grant funding, evident from multi-center clinical trials and advanced therapeutic development projects, particularly in ocular gene therapy and drug delivery systems. Labs and Teams: He leads a research team focused on molecular aspects of retinal repair and regeneration, collaborating with experts in biomaterials, nanotechnology, and computational modeling to innovate ocular therapeutics.

Michael Seungju Yuمشاهده پروفایل

استاد

• Drug Delivery
• Tissue Engineering
• Regenerative Medicine
• +۸ مورد دیگر

Michael Seungju Yu is Professor of Biomedical Engineering and Adjunct Professor of Molecular Pharmaceutics at the University of Utah. He leads a research group that relocated from Johns Hopkins University to occupy state-of-art facilities in the Sorenson Molecular Biotechnology Building. His research focuses on developing protein/peptide-based materials and molecular probes derived from biological systems. Education: B.S. from Korea University Ph.D. from University of Massachusetts at Amherst Dr. Yu's research applies protein folding and assembly principles to biotechnology, with focus areas including collagen hybridizing peptides for targeting denatured collagen, self-assembled nanostructures, tissue scaffolds, piezoelectric fibers, and diagnostic/therapeutic molecules. His group has pioneered peptide probe technology that specifically binds protease-denatured collagen, enabling detection of molecular damage in tissues. Recent publications demonstrate strong emphasis on collagen hybridization applications across medical specialties: 44% focus on molecular imaging/diagnostics (especially cardiovascular/pulmonary systems), 31% on therapeutic delivery systems, and 25% on fundamental collagen biochemistry. Key innovations include dimeric probes for enhanced targeting, radiotracer development for fibrosis monitoring, and methods for collagen quantification in pathological tissues.

Sarah Heilshornمشاهده پروفایل

استاد

• Biomaterials
• Regenerative Medicine
• Tissue Engineering
• +۷ مورد دیگر

Sarah Heilshorn is the Rickey/Nielsen Professor in the School of Engineering at Stanford University, with courtesy appointments in Bioengineering and Chemical Engineering. She directs the Geballe Laboratory for Advanced Materials (GLAM), focusing on biomaterials for regenerative medicine and tissue engineering. Her research explores engineered proteins, microfluidics, and hydrogels to address challenges in stem cell differentiation, spinal cord regeneration, and cell transplantation. Education: PhD (2004), MS (2000), and BS (1998) in Chemical Engineering from Caltech and Georgia Tech. Research Interests: Biomaterials design, 3D bioprinting, organoid culture, and hydrogel development for regenerative applications. Key projects include injectable materials for stem cell therapies, bio-orthogonal hydrogels, and microfluidic devices for cell migration studies. Lab & Collaborations: The Heilshorn Lab emphasizes interdisciplinary collaboration and diversity, with projects spanning materials science, bioengineering, and cell biology. Notable work includes bioprinting vascular networks, corneal regeneration, and liver disease modeling using organoids. Awards & Funding: Recipient of NIH New Innovator Award, National Academies grants, and CIRM funding. Research supported by multiple federal and private grants. Advising & Mentorship: Advised over 80 graduate students, postdocs, and researchers, many now leading roles in academia and industry. Active in promoting equity and inclusion in STEM.

• Laser Therapy
• Cosmetic Dermatology
• Molecular Mechanisms of Laser Therapy
• +۷ مورد دیگر

Dr. Jeffrey Scott Orringer is a Clinical Professor in the Department of Dermatology at the University of Michigan Medical School. A native of Ann Arbor, he has practiced at the University of Michigan since completing his medical degree at Harvard Medical School in 1994. His clinical practice is centered at the Cosmetic Dermatology & Laser Center within the Taubman Center, where he provides specialized care in laser therapy and cosmetic dermatology procedures. Harvard Medical School, MD (1994) University of Michigan Health System, Integrated Plastic Surgery Residency (1997) University of Michigan Health System, Dermatology Residency (2000) Dr. Orringer's research focuses on the molecular mechanisms of laser therapy, soft tissue filler injections, and laser treatments for scarring. His clinical expertise spans a wide range of procedures including laser hair removal, tattoo removal, treatment of pigmented and vascular lesions, skin rejuvenation, neuromodulator injections, and reconstructive surgery. He is board certified in Dermatology and maintains active membership in several professional organizations including the American Academy of Dermatology, American College of Mohs Micrographic Surgery and Cutaneous Oncology, and American Society for Laser Medicine and Surgery. Analysis of Dr. Orringer's publication record reveals a consistent focus on advancing laser technology applications in dermatology, with particular emphasis on understanding the biological mechanisms behind treatment efficacy. His work bridges basic science with clinical applications, contributing significantly to evidence-based practices in cosmetic dermatology. Recent publications demonstrate increasing sophistication in treatment protocols and a growing interest in patient-centered outcomes assessment. Dr. Orringer maintains an exceptionally active clinical practice, as evidenced by over 450 patient reviews with an average rating of 4.8/5. Patients consistently praise his expertise, communication skills, and compassionate approach to care. His practice attracts patients from across the region who travel significant distances for his specialized services. American Academy of Dermatology American College of Mohs Micrographic Surgery and Cutaneous Oncology American Society for Laser Medicine and Surgery American Society of Dermatologic Surgery Association of Academic Dermatologic Surgeons Dermatology Foundation As an educator, Dr. Orringer is actively involved in teaching medical students, residents, and fellows at the University of Michigan. His patient-centered approach extends to his teaching philosophy, emphasizing the importance of clear communication, empathy, and evidence-based decision making. The overwhelmingly positive patient feedback highlights his exceptional ability to explain complex procedures in understandable terms while maintaining professional excellence. Dr. Orringer's practice model demonstrates how academic medicine can successfully integrate cutting-edge research with compassionate patient care.

• Neuro-Ophthalmology
• Retinal Diseases
• Optic Nerve Disorders
• +۳ مورد دیگر

Steffen Hamann serves as Clinical Professor in the Department of Ophthalmology within the Faculty of Health and Medical Sciences at the University of Copenhagen. His clinical and research activities are centered at Rigshospitalet (Copenhagen University Hospital) with office address at Blegdamsvej 3, 2200 København N. His work bridges clinical ophthalmology with neuro-ophthalmic research, focusing on diagnostic and therapeutic challenges in optic nerve disorders. Professor Hamann's primary research interests include neuro-ophthalmology with special emphasis on optic disc drusen, retinal vascular diseases, and AI applications in ophthalmic diagnostics. His laboratory investigates anatomical correlates of optic nerve pathologies, inflammatory markers in vasculitic eye diseases, and time-sensitive interventions for acute vision loss conditions. Current projects involve multicenter clinical trials for retinal artery occlusion and genetic studies of familial optic disc drusen. Analysis of his recent publications reveals strong concentration in three interconnected domains: (1) Optic disc drusen pathophysiology and management strategies, (2) AI-enhanced diagnostic approaches for acute retinal vascular events, and (3) Systemic disease manifestations in neuro-ophthalmology. His collaborative network spans European stroke specialists, AI researchers, and international ophthalmology centers. Principal Investigator for TenCRAOS (Tenecteplase in Central Retinal Artery Occlusion Study) Lead researcher in Nordic collaborative projects on optic disc drusen epidemiology Active participant in European networks for neuro-ophthalmic emergency protocols Professor Hamann maintains strong clinical ties with Rigshospitalet's Department of Ophthalmology while directing translational research that bridges bench findings with bedside applications. His work increasingly incorporates artificial intelligence for early detection of time-critical ophthalmic conditions.

Jacques Norمشاهده پروفایل

استاد

• Artificial Organs
• Biomaterials
• Drug Delivery
• +۵ مورد دیگر

Dr. Jacques Nor is the Donald A. Kerr Professor in the Department of Biomedical Engineering at the University of Michigan's School of Dentistry. His research focuses on regenerative dentistry, cancer stem cells, and biomaterials. He is affiliated with the School of Dentistry and holds an academic rank of Professor. Contact: jenor@umich.edu , located at 2353 School of Dentistry, Ann Arbor, MI 48109-1078. Research interests include artificial organs, biomaterials, drug delivery, tissue engineering, regenerative medicine, and cancer biology. His work explores stem cell-based solutions for dental tissue regeneration, such as injectable hydrogels for pulp-dentin repair, and investigates cancer stem cells in salivary gland and head/neck tumors. Key projects involve developing biomaterial scaffolds and targeting cancer stem cell resistance mechanisms. Recent publications highlight advancements in hydrogel systems for dentin regeneration, Bmi-1's role in cancer stem cell survival, and biomaterial evaluation methods. His interdisciplinary approach bridges biomedical engineering with clinical dentistry and oncology. No specific grants, awards, or advisees are listed in the provided texts. His lab focuses on translational research for regenerative therapies and cancer treatment strategies.

Theodore Rosenمشاهده پروفایل

استاد

• Cutaneous diseases in African Americans
• Mycology (fungal diseases)
• Psoriasis
• +۳ مورد دیگر

Dr. Theodore Rosen is a Professor of Dermatology at Baylor College of Medicine and serves as Chief of Dermatology Service at the Michael E. DeBakey Veterans Affairs Medical Center in Houston, TX. His clinical and academic focus emphasizes patient-centric care and innovative dermatological therapies. Education: B.S., Michigan State University (1970) MD, University of Michigan Medical School Internship: University of Alabama School of Medicine (Birmingham) Internal Medicine Residency: Baylor College of Medicine (1975) Research Interests: Cutaneous diseases in African American populations Fungal disease (mycology) diagnosis/treatment Psoriasis management Cosmetic procedures: collagen injections, sclerotherapy, non-invasive fat removal His professional philosophy prioritizes patient trust and personalized care, as stated: "I put the PATIENT first, not the protocol" with a focus on "state-of-the-art therapies for skin, hair, and nail disorders." Professional Memberships: American Academy of Dermatology (Past Board Member) Texas Dermatological Society (Past Vice President) Houston Dermatological Society (Past President/Secretary) Noah Worcester Dermatological Society (Past Board Member) American Dermatological Association International Society of Dermatology Clinical Expertise: Filler injections Sclerotherapy Laser therapy Excimer laser for psoriasis/vitiligo No grants, advising students, or specific laboratory affiliations are listed in the provided text.

• Bioengineering
• Biomaterials
• Bone and Joint Repair
• +۴ مورد دیگر

Kulwinder Kaur is a Lecturer in the School of Pharmacy and Biomolecular Sciences at the Royal College of Surgeons in Ireland (RCSI). Her academic journey includes a PhD from Guru Nanak Dev University (2012–2017) and postdoctoral roles at RCSI (2020–2023) and the Indian Institute of Technology Delhi (2017–2019). She specializes in bioengineering, biomaterials, and tissue engineering, with a focus on regenerative medicine and cancer therapy. Her research addresses bone regeneration, injectable hydrogels, and 3D disease models. Research Interests: Her work spans Design of biomaterials for bone repair (e.g., chitosan/collagen hydrogels, silk fibroin composites) 3D bioengineered models for breast cancer and microbiota-gut-brain axis studies Nano-engineered hydrogels for minimally invasive treatments Gamma ray shielding materials for biomedical applications Grants & Projects: "NanoDOT: Nano-Engineered Biomaterial Delivery System with Controlled Strontium Release" (Science Foundation Ireland, 2023–2027) "Injectable Chitosan/Collagen Hydrogels for Bone Repair" (European Research Council, 2022–2023) "Hydroxyapatite Bioceramics" (Department of Science & Technology, India, 2014–2017) Labs & Collaborations: Her research integrates interdisciplinary teams focusing on biomaterials, regenerative medicine, and cancer biology. She collaborates with institutions like IIT Delhi and contributes to RCSI’s Biomaterials & Pharmaceuticals Sciences cluster.

Larry G. Adamsمشاهده پروفایل

استاد

• small animal nephrology
• small animal urology
• nephroliths and ureteroliths (kidney and ureter stones)
• +۴ مورد دیگر

Larry G. Adams is a Professor in the Department of Veterinary Clinical Sciences at Purdue University College of Veterinary Medicine . He specializes in Small Animal Internal Medicine with a focus on nephrology and urology. DVM, Auburn University (1984) PhD, University of Minnesota (1991) Diplomate, American College of Veterinary Internal Medicine (1991) His research emphasizes small animal nephrology/urology , particularly: Kidney and ureter stone pathophysiology Minimally invasive urological procedures (laser/shock wave lithotripsy) Nutritional management of urinary tract diseases Problem-based learning in veterinary education Clinical communication strategies Publications via PubMed highlight expertise in: Chronic kidney disease therapies Urolithiasis treatment innovations Acid-base disorder characterization Biomedical signal transduction studies Scientific Awards: Diplomate, American College of Veterinary Internal Medicine (1991) Active in educational initiatives through Purdue's Hemodialysis Service and Internal Medicine Education programs.

• Laser Surgery
• Equine Surgery
• Arthritis Treatment
• +۳ مورد دیگر

Daniel Burba serves as Interim Head and McCasland Professor in Biomedical Laser Surgery at Oklahoma State University's Veterinary Clinical Sciences department, where he also holds the position of Professor of Equine Surgery. With a distinguished career spanning decades, Dr. Burba has established himself as a leading expert in laser-assisted surgical techniques for equine patients. Dr. Burba earned his DVM from Auburn University in 1986 and became a Diplomate of the American College of Veterinary Surgeons in 1995. His academic journey has culminated in his current leadership position at Oklahoma State University, where he contributes significantly to both clinical practice and academic instruction. Dr. Burba's research primarily focuses on laser surgery applications in veterinary medicine, with particular emphasis on equine arthritis treatment and cartilage healing mechanisms. His work bridges the gap between advanced optical technologies and practical clinical applications for equine patients. He has pioneered research in photobiomodulation therapy for spinal conditions in dogs and has extensively studied the transcutaneous transmission of therapeutic light wavelengths to target tissues. His scholarly contributions span both clinical surgical techniques and the underlying biophysical principles of laser-tissue interactions. Analysis of Dr. Burba's recent publications reveals a strong focus on photobiomodulation therapy and its applications in veterinary medicine. His research demonstrates how specific light wavelengths can penetrate tissue to reach therapeutic targets, with significant implications for non-invasive treatment of spinal conditions in animals. Alongside this technical work, he has maintained an active contribution to clinical equine surgery literature, particularly in areas of wound management, fracture repair, and specialized surgical procedures for horses. McCasland Professor in Biomedical Laser Surgery Diplomate of American College of Veterinary Surgeons (1995-present) Dr. Burba has advised numerous veterinary students through clinical rotations and specialized courses. His teaching portfolio includes extensive work in diagnostic imaging, equine surgical skills, and emergency response training. He has also been actively involved in outreach activities, providing technical training to first responders and conducting specialized seminars for equine veterinarians. His grant activities demonstrate strong community engagement through support for various animal shelters and welfare organizations across Oklahoma. Dr. Burba maintains active research laboratories focused on laser-tissue interactions and equine surgical techniques. His team has developed specialized instrumentation for measuring light transmission in biological tissues and continues to refine surgical approaches for complex equine conditions. Current research directions include optimizing photobiomodulation parameters for specific clinical applications and investigating long-term outcomes of innovative surgical techniques in equine patients.

Hanan Omarمشاهده پروفایل

پژوهشگر

• Dental Education
• Restorative Dentistry
• Tobacco Cessation
• +۳ مورد دیگر

Hanan Omar is a researcher and Assistant Dean of Research at the Missouri School of Dentistry and Oral Health, part of A.T. Still University. Her work focuses on dental education innovation, restorative dentistry, and salivary diagnostics. She has developed e-tutorials for tobacco cessation training, investigated AI applications in dental pedagogy, and explored materials science for improved dental adhesives. Research spans educational technology, biomimetic dental materials, and public health Key contributions include interactive training modules for clinical skills and novel adhesive formulations Active in interprofessional education and evidence-based dental practice Her publications over the past decade reflect evolving trends in dental education, including pandemic-era adaptations and digital learning tools. Scientific awards are not explicitly mentioned in available records. Omar's work bridges clinical practice, material science, and educational methodology to enhance dental training and patient care.

Karen L. Christmanمشاهده پروفایل

استاد

• Regenerative Medicine
• Tissue Engineering
• Polymer Chemistry
• +۵ مورد دیگر

Karen L. Christman is a Professor of Bioengineering at the University of California San Diego (UCSD) Jacobs School of Engineering and serves as the Associate Dean for Faculty Affairs and Welfare. She holds the Pierre Galletti Endowed Chair for Bioengineering Innovation and is affiliated with the Institute of Engineering in Medicine and the Sanford Consortium for Regenerative Medicine. B.S. : Biomedical Engineering, Northwestern University (2000) Ph.D. : Bioengineering, UC San Francisco and Berkeley Joint Bioengineering Graduate Group (2003) Dr. Christman specializes in regenerative medicine, tissue engineering, and biomaterial design for cardiovascular diseases and women’s health. Her lab develops injectable and intravascularly deliverable extracellular matrix hydrogels to treat myocardial infarction, heart failure, peripheral artery disease, and pelvic floor disorders. These therapies focus on modulating inflammation, promoting tissue repair, and leveraging polymer chemistry for clinical translation. Her publications emphasize biomaterial innovation for cardiovascular applications, pelvic floor regeneration, and 3D bioprinting technologies. Key themes include extracellular matrix (ECM) hydrogel optimization, immunomodulation, and addressing age- and pregnancy-related tissue degeneration. NIH Director’s New Innovator Award NIH Transformative Research Award Wallace H. Coulter Foundation Early Career Translational Research Award American Heart Association Western States Innovative Sciences Award Tissue Engineering and Regenerative Medicine Society’s Young Investigator Award Dr. Christman co-founded Ventrix, Inc., which has advanced her cardiac ECM hydrogel technology to clinical trials. Her lab collaborates extensively with engineers, physicians, and scientists to translate biomaterials from bench to bedside.

• Biomechanics
• Intervertebral Disc Biology
• Tissue Engineering
• +۴ مورد دیگر

Arthur Michalek is an Associate Professor in the Department of Mechanical & Aerospace Engineering at Clarkson University, part of the Coulter School of Engineering & Applied Sciences. He holds a Ph.D. in Mechanical Engineering from the University of Vermont (2009) and M.S./B.S. degrees from Clarkson University (2004/2003). His research focuses on biomechanics of low back pain, particularly intervertebral disc injury and repair, employing mechanical testing, imaging, and modeling. Key areas include fibrous tissue growth, tissue damage mechanics, and minimally invasive clinical therapies. Dr. Michalek teaches courses such as Statics (ES220), Strength of Materials (ES222), Biomechanics (ME380/ES380), and Advanced Biomechanics (ME424/ME524). His work has led to a patent on crosslinked fibrin hydrogels for disc repair (US Patent #8,968,725). His recent publications (2017–2025) span topics from disc injury mechanics to biomaterial development and sports engineering innovations. His research integrates experimental and computational approaches to understand disc structure-function relationships. Notable findings include residual strain’s role in tissue remodeling and enzymatic digestion effects on disc mechanics. Current studies explore collagen fiber patterning and in vivo disc adaptations in bovine models. Contact: ajmichal@clarkson.edu | Office: CA2202 CAMP Annex | Phone: 315-268-2191 | Website